Avoidant/Restrictive Food Intake Disorder (ARFID): A Comprehensive Review of Etiology, Diagnosis, and Emerging Research Directions

Avoidant/Restrictive Food Intake Disorder (ARFID): A Comprehensive Review of Etiology, Diagnosis, and Emerging Research Directions

Abstract

Avoidant/Restrictive Food Intake Disorder (ARFID) is a relatively newly defined eating disorder characterized by persistent failure to meet appropriate nutritional and/or energy needs, not driven by concerns about body shape or weight. This review provides a comprehensive overview of ARFID, encompassing its historical context, diagnostic criteria, proposed etiologies, assessment methods, and current understanding of its prevalence and impact. Furthermore, it critically examines the limitations of the current diagnostic framework and explores emerging research directions that aim to refine our understanding of this complex disorder. This includes discussions on the role of sensory sensitivity, gastrointestinal dysfunction, and anxiety disorders in the development and maintenance of ARFID, as well as the application of novel neuroimaging and genetic approaches to elucidate the underlying biological mechanisms. The review concludes by highlighting the urgent need for improved diagnostic tools, evidence-based treatment strategies, and longitudinal studies to improve the long-term outcomes for individuals with ARFID.

1. Introduction

Avoidant/Restrictive Food Intake Disorder (ARFID) was officially recognized as a distinct eating disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) in 2013, replacing the previous category of “Feeding Disorder of Infancy or Early Childhood” (DSM-IV). This change reflected a growing recognition that restrictive eating patterns not motivated by body image concerns could lead to significant medical and psychosocial consequences across the lifespan, not just in early childhood (American Psychiatric Association, 2013). While anorexia nervosa (AN) and bulimia nervosa (BN) are characterized by disturbances in body image and fear of weight gain, individuals with ARFID restrict their food intake due to a variety of factors, including sensory sensitivities, fear of aversive consequences (e.g., choking, vomiting), or a general lack of interest in eating. This seemingly simple distinction, however, belies a complex and heterogeneous clinical presentation, making ARFID a challenging disorder to diagnose and treat.

The inclusion of ARFID in the DSM-5 represented a significant step forward in recognizing the diverse range of eating disorders that can impact individuals of all ages, genders, and backgrounds. It acknowledged that significant nutritional deficiencies and functional impairments could arise from restrictive eating patterns even in the absence of body image distortions. However, the relatively recent recognition of ARFID as a distinct entity has resulted in a paucity of research compared to other eating disorders like AN and BN. This lack of research has significant implications for our understanding of ARFID’s etiology, prevalence, and optimal treatment strategies.

This review aims to provide a comprehensive overview of ARFID, critically examining the current state of knowledge and highlighting areas where further research is urgently needed. We will delve into the diagnostic criteria, proposed etiological factors, assessment methods, prevalence, and impact of ARFID. Furthermore, we will explore the limitations of the current diagnostic framework and discuss emerging research directions that promise to advance our understanding of this complex and often misunderstood disorder.

2. Diagnostic Criteria

The DSM-5 diagnostic criteria for ARFID are as follows:

• A. An eating or feeding disturbance (e.g., apparent lack of interest in eating or food; avoidance based on the sensory characteristics of food; concern about aversive consequences of eating) as manifested by persistent failure to meet appropriate nutritional and/or energy needs associated with one (or more) of the following:
  • Significant weight loss (or failure to achieve expected weight gain or faltering growth in children).
  • Significant nutritional deficiency.
  • Dependence on enteral feeding or oral nutritional supplements.
  • Marked interference with psychosocial functioning.
• B. The disturbance is not better explained by lack of available food or by an associated culturally sanctioned practice.
• C. The disturbance does not occur exclusively during the course of anorexia nervosa or bulimia nervosa, and there is no evidence of a disturbance in the way in which one’s body weight or shape is experienced.
• D. The eating disturbance is not attributable to a concurrent medical condition or not better explained by another mental disorder. When the eating disturbance occurs in the context of another condition or disorder, the severity of the eating disturbance exceeds that routinely associated with the condition or disorder and warrants additional clinical attention.

The A criteria highlights the core feature of ARFID: a persistent disturbance in eating or feeding that results in significant nutritional and/or energy deficits. This disturbance can manifest in various ways, including a general lack of interest in eating, avoidance based on sensory characteristics of food (e.g., texture, taste, smell), or a fear of aversive consequences (e.g., choking, vomiting, abdominal pain). The consequences of this disturbance are outlined in the A criteria and include weight loss (or failure to gain weight), nutritional deficiencies, dependence on artificial nutrition, and impaired psychosocial functioning.

The exclusion criteria (B, C, and D) are critical for differentiating ARFID from other conditions. Criterion B ensures that the eating disturbance is not simply due to a lack of access to food or culturally normative practices (e.g., fasting for religious purposes). Criterion C distinguishes ARFID from anorexia nervosa and bulimia nervosa by emphasizing the absence of body image disturbance. Finally, criterion D addresses the issue of comorbidity, stating that the eating disturbance must be beyond what would be expected from an underlying medical or mental health condition. It is important to emphasize that ARFID can co-occur with other conditions, but the eating disturbance must warrant independent clinical attention.

The heterogeneity of ARFID presentation is a major challenge. Some individuals may exhibit extreme pickiness and restrict their diet to a very limited range of foods due to sensory aversions. Others may have experienced a traumatic event related to eating (e.g., choking) and develop a fear of specific foods or textures. Still others may have a general lack of interest in food and struggle to meet their nutritional needs. This variability necessitates a thorough and individualized assessment to identify the specific factors driving the restrictive eating patterns.

3. Etiology

The etiology of ARFID is likely multifactorial, involving a complex interplay of genetic, biological, psychological, and environmental factors. However, due to the relative recency of ARFID as a distinct diagnostic entity, research on its etiology is still in its early stages.

3.1 Genetic and Biological Factors:

While specific genes linked to ARFID have not yet been identified, family studies have suggested a possible genetic component to eating disorders in general (Berrettini, 2004). It is plausible that genetic predispositions to anxiety, sensory sensitivities, and gastrointestinal issues may increase the risk of developing ARFID. Furthermore, neuroimaging studies are beginning to explore potential differences in brain structure and function in individuals with ARFID compared to healthy controls. For example, some studies have suggested that individuals with ARFID may exhibit altered reward processing in response to food cues (Foerde et al., 2019), which could contribute to their lack of interest in eating. Future research using larger samples and more sophisticated neuroimaging techniques is needed to further elucidate the role of genetic and biological factors in ARFID.

3.2 Psychological Factors:

Psychological factors play a significant role in the development and maintenance of ARFID. Anxiety disorders, particularly social anxiety disorder, obsessive-compulsive disorder (OCD), and specific phobias (e.g., emetophobia – fear of vomiting), are commonly comorbid with ARFID (Burton Murray et al., 2021). These anxiety disorders can contribute to the development of restrictive eating patterns through various mechanisms. For example, individuals with emetophobia may avoid a wide range of foods that they perceive as potential triggers for vomiting. Similarly, individuals with OCD may develop rigid food rituals and restrictions to reduce anxiety associated with contamination or other obsessions.

Sensory sensitivities are another important psychological factor in ARFID. Many individuals with ARFID report heightened sensitivity to the taste, texture, smell, or appearance of food. These sensory aversions can lead to the avoidance of specific foods or entire food groups, resulting in a limited and nutritionally inadequate diet. The underlying mechanisms of sensory sensitivities in ARFID are not fully understood, but may involve differences in sensory processing in the brain or heightened emotional reactivity to sensory stimuli.

3.3 Environmental Factors:

Environmental factors can also contribute to the development of ARFID. Traumatic experiences related to food, such as choking, severe allergic reactions, or food poisoning, can lead to the development of fear and avoidance of specific foods. Furthermore, certain feeding practices during childhood, such as coercive feeding or negative mealtime interactions, may contribute to the development of ARFID (Chatoor, 2009). The social environment can also play a role, as individuals may be influenced by the eating habits and attitudes of their family and peers. It’s also important to consider the accessibility and availability of a variety of foods as potential environmental factors.

4. Prevalence and Impact

Estimating the prevalence of ARFID is challenging due to the relatively recent recognition of the disorder and the lack of standardized diagnostic criteria and assessment tools. Epidemiological studies on ARFID are still limited, and prevalence estimates vary widely depending on the population studied and the methods used. However, available data suggest that ARFID may be more common than previously thought.

Studies in pediatric populations have reported prevalence rates of ARFID ranging from 0.5% to 3.2% (Nicely et al., 2014; Fisher et al., 2014). In clinical samples, ARFID has been found to be more prevalent than anorexia nervosa in some settings (Norris et al., 2014). While ARFID was initially thought to primarily affect children and adolescents, it is now recognized that the disorder can occur at any age, including adulthood (Bryant-Waugh et al., 2010). The prevalence of ARFID in adult populations is largely unknown, but some studies suggest that it may be underdiagnosed.

The impact of ARFID on physical and psychosocial health can be significant. Nutritional deficiencies can lead to a wide range of medical complications, including growth retardation, delayed puberty, bone loss, anemia, and impaired immune function (Thomas et al., 2017). In severe cases, ARFID can be life-threatening. Furthermore, ARFID can have a significant impact on psychosocial functioning. Individuals with ARFID may experience social isolation, anxiety, depression, and difficulties with academic or occupational performance (Burton Murray et al., 2021). The restrictive eating patterns associated with ARFID can also place a significant burden on families and caregivers.

5. Assessment

A thorough assessment is crucial for the accurate diagnosis and effective treatment of ARFID. The assessment should include a comprehensive evaluation of the individual’s eating history, medical history, psychological functioning, and social environment.

5.1 Clinical Interview:

A detailed clinical interview is essential for gathering information about the individual’s eating patterns, food preferences, sensory sensitivities, and history of aversive experiences related to food. The interview should also assess for the presence of comorbid anxiety disorders, mood disorders, and other mental health conditions. It is important to ask about the impact of the eating disturbance on the individual’s daily life, including their social, academic, and occupational functioning. In children and adolescents, it is crucial to involve parents or caregivers in the interview process to obtain a comprehensive understanding of the child’s eating behaviors.

5.2 Standardized Questionnaires:

Several standardized questionnaires have been developed to assess eating disorder symptoms and related psychological constructs. While there are currently no questionnaires specifically designed for ARFID, several existing measures can be adapted to assess relevant symptoms. For example, the Eating Disorder Examination Questionnaire (EDE-Q) can be used to assess the severity of eating disorder behaviors and attitudes, even though it focuses on body image. Measures of anxiety, depression, and sensory sensitivity can also be helpful in identifying comorbid conditions and understanding the factors contributing to the restrictive eating patterns. The Nine Item ARFID Screen (NIAS) is one of the few measures that specifically screens for ARFID characteristics (Brunklaus et al, 2023).

5.3 Medical Evaluation:

A medical evaluation is necessary to assess the individual’s nutritional status and identify any medical complications resulting from the restrictive eating patterns. This evaluation should include a physical examination, assessment of vital signs, and laboratory tests to measure electrolyte levels, kidney function, liver function, and vitamin and mineral levels. Depending on the individual’s presentation, additional tests may be necessary to rule out other medical conditions that could be contributing to the eating disturbance.

5.4 Dietary Assessment:

A dietary assessment is essential for evaluating the individual’s dietary intake and identifying any nutritional deficiencies. This assessment can be conducted using various methods, including food diaries, 24-hour recalls, and food frequency questionnaires. It is important to obtain detailed information about the types and amounts of foods consumed, as well as any dietary restrictions or avoidances. The dietary assessment should be conducted by a registered dietitian or other qualified healthcare professional.

6. Limitations of the Current Diagnostic Framework

The DSM-5 criteria for ARFID represent a significant improvement over previous diagnostic systems, but they are not without limitations. One major limitation is the heterogeneity of the disorder. ARFID can manifest in various ways, making it difficult to develop a single set of criteria that adequately captures the diverse range of clinical presentations. The current criteria may not fully capture the nuances of sensory-based food avoidance, fear of aversive consequences, or general lack of interest in eating.

Another limitation is the lack of specific guidance on how to assess the severity of the eating disturbance. The DSM-5 criteria require that the eating disturbance result in significant weight loss, nutritional deficiency, dependence on artificial nutrition, or impaired psychosocial functioning. However, there is no clear definition of what constitutes “significant” or “marked.” This lack of specificity can make it difficult to determine whether an individual meets the diagnostic criteria for ARFID, particularly in cases where the eating disturbance is mild or moderate.

Furthermore, the exclusion criteria for ARFID can be challenging to apply in clinical practice. Differentiating ARFID from other conditions, such as anorexia nervosa or medical conditions, can be complex, particularly in cases where there is overlap in symptoms. For example, some individuals with anorexia nervosa may initially restrict their food intake due to sensory sensitivities or a lack of interest in eating, before developing body image concerns. In these cases, it can be difficult to determine whether the primary diagnosis is ARFID or anorexia nervosa.

7. Emerging Research Directions

Given the limitations of the current diagnostic framework and the paucity of research on ARFID, there is an urgent need for further investigation to refine our understanding of this complex disorder. Several promising research directions are emerging that hold the potential to advance our knowledge of ARFID’s etiology, diagnosis, and treatment.

7.1 Neuroimaging Studies:

Neuroimaging studies are beginning to explore the neural correlates of ARFID. These studies are investigating differences in brain structure and function in individuals with ARFID compared to healthy controls, as well as examining the neural mechanisms underlying sensory processing, reward processing, and anxiety. Future neuroimaging studies using larger samples and more sophisticated techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), can provide valuable insights into the biological basis of ARFID.

7.2 Genetic Studies:

Genetic studies are needed to identify specific genes that may increase the risk of developing ARFID. These studies can use various approaches, including genome-wide association studies (GWAS) and candidate gene studies, to examine the association between genetic variants and ARFID. Identifying specific genes linked to ARFID could lead to the development of more targeted interventions and prevention strategies.

7.3 Longitudinal Studies:

Longitudinal studies are essential for understanding the long-term course of ARFID and identifying factors that predict prognosis. These studies should follow individuals with ARFID over time, assessing their eating behaviors, nutritional status, psychological functioning, and social environment at regular intervals. Longitudinal studies can provide valuable information about the natural history of ARFID and help to identify critical periods for intervention.

7.4 Development of Standardized Assessment Tools:

There is a need for the development of standardized assessment tools specifically designed for ARFID. These tools should include comprehensive measures of eating behaviors, sensory sensitivities, anxiety, and psychosocial functioning. The development of standardized assessment tools will improve the accuracy and reliability of ARFID diagnosis and facilitate research on the disorder.

7.5 Treatment Outcome Studies:

Further research is needed to evaluate the effectiveness of different treatment approaches for ARFID. Randomized controlled trials (RCTs) should be conducted to compare the efficacy of different interventions, such as cognitive-behavioral therapy (CBT), family-based therapy (FBT), and nutritional rehabilitation. These studies should also examine the long-term outcomes of treatment and identify factors that predict treatment success.

8. Conclusion

Avoidant/Restrictive Food Intake Disorder (ARFID) is a complex and heterogeneous eating disorder that can have significant medical and psychosocial consequences. While the inclusion of ARFID in the DSM-5 has increased awareness of the disorder, research on its etiology, diagnosis, and treatment is still in its early stages. The limitations of the current diagnostic framework and the paucity of evidence-based treatment strategies highlight the urgent need for further investigation. Emerging research directions, such as neuroimaging studies, genetic studies, longitudinal studies, and the development of standardized assessment tools, hold the potential to advance our understanding of ARFID and improve the lives of individuals affected by this disorder. A collaborative effort involving researchers, clinicians, and policymakers is essential to address the challenges and opportunities in the field of ARFID and ensure that individuals with this disorder receive the care and support they need.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://doi.org/10.1176/appi.books.9780890425596

Berrettini, W. H. (2004). The genetics of eating disorders. Psychiatric Clinics of North America, 27(3), 331–339.

Brunklaus, A., Campbell, K., & Kohn, M. (2023). Nine Item ARFID Screen (NIAS): Development and validation of a screening tool for children and adolescents. Eating and Weight Disorders – Studies on Anorexia, Bulimia and Obesity, 28(1), 14. https://doi.org/10.1007/s40519-022-01502-x

Bryant-Waugh, R., Markham, L., Kreipe, R. E., & Walsh, B. T. (2010). Feeding and eating disorders in childhood. International Journal of Eating Disorders, 43(2), 98–111.

Burton Murray, H., Allen, K. L., and Keshawarz, A. (2021). Avoidant/Restrictive Food Intake Disorder (ARFID): A Review of the Current State of Knowledge. Current Nutrition Reports, 10, 313–327.

Chatoor, I. (2009). Feeding disorders of infancy and early childhood. In M. Lewis & L. T. Szynalaski (Eds.), Child and adolescent psychiatry: A comprehensive textbook (4th ed., pp. 545-558). Lippincott Williams & Wilkins.

Fisher, M. M., Rosen, D. S., Schneider, M., Accurso, E. J., Fitzsimmons-Craft, E. E., Le Grange, D., & Lock, J. (2014). Characteristics of avoidant/restrictive food intake disorder in children and adolescents: A “new disorder” in DSM-5. Journal of Adolescent Health, 55(1), 49–52.

Foerde, K., Steinglass, J. E., Walsh, B. T., Shohamy, D., & Simpson, H. B. (2019). Neural mechanisms of reward processing in avoidant/restrictive food intake disorder. Neuropsychopharmacology, 44(7), 1230–1237.

Nicely, T. A., Lane-Loney, K. J., Fewell, R. L., Bohon, C., & Stallings, V. A. (2014). ARFID: A systematic review and meta-analysis. International Journal of Eating Disorders, 47(7), 649–658.

Norris, J. M., Spettigue, W., & Katzman, D. K. (2014). Update on eating disorders: Current perspectives on avoidant/restrictive food intake disorder in children and adolescents. Journal of Adolescent Health, 55(1), 20–25.

Thomas, J. J., Lawson, E. A., Micali, N., Misra, M., Deckersbach, T., & Eddy, K. T. (2017). Avoidant/restrictive food intake disorder: A systematic review of the current state of research. Eating Disorders, 25(5), 513–535.